Reply : Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk
| Errataetall: |
CommentOn: Ann Pharmacother. 2022 Mar;56(3):237-244. - PMID 34180274 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
The Annals of pharmacotherapy - 56(2022), 4 vom: 12. Apr., Seite 507-508 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Xian Jie Cindy [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adrenal Cortex Hormones |
|---|
| Anmerkungen: |
Date Completed 09.03.2022 Date Revised 07.12.2022 published: Print-Electronic CommentOn: Ann Pharmacother. 2022 Mar;56(3):237-244. - PMID 34180274 Citation Status MEDLINE |
|---|
| doi: |
10.1177/10600280211036047 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328747645 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328747645 | ||
| 003 | DE-627 | ||
| 005 | 20231225203612.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/10600280211036047 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1095.xml |
| 035 | |a (DE-627)NLM328747645 | ||
| 035 | |a (NLM)34330173 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Xian Jie Cindy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reply |b Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.03.2022 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Ann Pharmacother. 2022 Mar;56(3):237-244. - PMID 34180274 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a tocilizumab |2 NLM | |
| 650 | 7 | |a I031V2H011 |2 NLM | |
| 700 | 1 | |a Altshuler, Diana |e verfasserin |4 aut | |
| 700 | 1 | |a Spiegler, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Brosnahan, Shari B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Annals of pharmacotherapy |d 1993 |g 56(2022), 4 vom: 12. Apr., Seite 507-508 |w (DE-627)NLM012749435 |x 1060-0280 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2022 |g number:4 |g day:12 |g month:04 |g pages:507-508 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/10600280211036047 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2022 |e 4 |b 12 |c 04 |h 507-508 | ||